According to the New York Newswire published on January 26th, 2016, Relmada Therapeutics Inc filed a lawsuit against Laidlaw and Company. Relmada Therapeutics is a company focused on generating initial therapies for chronic pain treatment. The movement to file an implemented complaint against the law firm is a component of the lawsuit. The company had initially filed the case in the District Court of Nevada. The complaint included an extra-legal case linked to a breach of contract by Laidlaw firm.
Breach of Contract
According to the case, Laidlaw Firm disclosed Relmada’s confidential information having acquired it from serving as the firm’s investment banker. In addition to the breach of contract, Relmada is demanding monetary compensation from the damages incurred during their response to Laidlaw’s false information and surrogate materials. The Court of Nevada previously issued a restraining order against Laidlaw firm and its two principals James Ahern and Matthew Eitner because of providing false information and proxy materials.
Laidlaw & Company is a high ranking investment banking and brokerage company. It specializes in providing personalized investment advice in addition to skillful execution to public and private institutions. It also offers investment services to high net worth investors at a personal level. With 170 years legacy in investment and banking, the firm focuses on the demands of domestic and international businesses, entrepreneurs and individual clients worldwide.
Laidlaw has an ever developing network of offices across and within the United States and Europe. It also has over 150 employees working under FCA authorization and while registered under FINRA. The two approvals allow the firm to generate relationships while pursuing new businesses and services while servicing clients globally. Laidlaw is characterized by an entrepreneurial relationship featured by a strong work ethic. For the employees, it is usually important to think outside the box by creating innovative strategies for investment.